The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Increased Risk for Demyelinating Diseases in Patients With Inflammatory Bowel Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATION
MICKEY, R. M., & GREENLAND, S. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115101 · Cited by 2,362
RE:“;THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATION”
Greenland, S., & Mickey, R. M. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115409 · Cited by 2,108
TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
MacDonald, B. K. (2000) · Brain · doi:10.1093/brain/123.4.665 · Cited by 858
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Use of the UK General Practice Research Database for pharmacoepidemiology
García Rodríguez, L. A., & Pérez Gutthann, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00701.x · Cited by 558
The epidemiology of multiple sclerosis
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802973-2.00011-2 · Cited by 514
The General Practice Research Database: Role in Pharmacovigilance
Wood, L., & Martinez, C. (2004) · Drug Safety · doi:10.2165/00002018-200427120-00004 · Cited by 331
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study
Hernán, M. A., Jick, S. S., Olek, M. J., & Jick, H. (2004) · Neurology · doi:10.1212/01.wnl.0000138433.61870.82 · Cited by 304
Inflammatory bowel disease is not associated with an increased risk of lymphoma
Lewis, J. D., Bilker, W. B., Brensinger, C., Deren, J. J., Vaughn, D. J., & Strom, B. L. (2001) · Gastroenterology · doi:10.1053/gast.2001.28703 · Cited by 296
Self-citationJick, H., Terris, B. Z., Derby, L. E., & Jick, S. S. (1992) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630010607 · Cited by 265
Inflammatory Bowel Disease Is Not Associated With An Increased Risk Of Lymphoma
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200112000-00025 · Cited by 250
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000
Mayr, W. T., Pittock, S. J., McClelland, R. L., Jorgensen, N. W., Noseworthy, J. H., & Rodriguez, M. (2003) · Neurology · doi:10.1212/01.wnl.0000094316.90240.eb · Cited by 243
Autoimmune disease in first-degree relatives of patients with multiple sclerosis
Broadley, S. A., Deans, J., Sawcer, S. J., Clayton, D., & Compston, D. A. S. (2000) · Brain · doi:10.1093/brain/123.6.1102 · Cited by 210
Edwards, L. J., & Constantinescu, C. S. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1087oa · Cited by 193
Lewis, J. D., Brensinger, C., Bilker, W. B., & Strom, B. L. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.698 · Cited by 189
Self-citationMortality in inflammatory bowel disease: a population-based cohort study
Card, T., Hubbard, R., & Logan, R. F. A. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.029 · Cited by 165
Prahalad, S., Shear, E. S., Thompson, S. D., Giannini, E. H., & Glass, D. N. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10370 · Cited by 158
Identification of A Prodromal Period in Crohn's Disease But Not Ulcerative Colitis
Pimentel, M., Chang, M. D., Chow, E. J., TABIBZADEH, S. S., Kirit-Kiriak, V., Targan, S., & Lin, H. C. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03361.x · Cited by 153
Martin, R. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.4.911 · Cited by 139
Demyelination During Anti-Tumor Necrosis Factor α Therapy With Infliximab for Crohn's Disease
Thomas, C. W., Weinshenker, B. G., & Sandborn, W. J. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200401000-00004 · Cited by 118
The VAMP research multi-purpose database in the U.K.
Lis, Y. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00137-f · Cited by 116
Bergsteinsdóttir, K., Yang, H.-T., Pettersson, U., & Holmdahl, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1564 · Cited by 112
Genetic Susceptibility to the Development of Autoimmune Disease
Heward, J. M., & Gough, S. C. L. (1997) · Clinical Science · doi:10.1042/cs0930479 · Cited by 111
Concurrence of Inflammatory Bowel Disease and Multiple Sclerosis
Kimura, K. B., Hunter, S. F., Thollander, M. S., Loftus, E. V., Melton, L. J., O’Brien, P. C., Rodriguez, M., & Phillips, S. F. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.8.802 · Cited by 111
Demyelination and inhibition of tumor necrosis factor (TNF).
Magnano, M. D., Robinson, W. H., & Genovese, M. C. (2004) · PubMed · Cited by 107
ASSOCIATION OF ULCERATIVE COLITIS WITH MULTIPLE SCLEROSIS
Rang, E. H., Brooke, Β. N., & Hermon-Taylor, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90629-8 · Cited by 104
Seasonal variation in flares of inflammatory bowel disease
Lewis, J. D., Aberra, F. N., Lichtenstein, G. R., Bilker, W. B., Brensinger, C. M., & Strom, B. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.003 · Cited by 101
Self-citationAutoimmunity in multiple sclerosis
Keyser, J. D. (1988) · Neurology · doi:10.1212/wnl.38.3.371 · Cited by 100
Concurrence of Multiple Sclerosis and Inflammatory Bowel Disease
Schiliro, G., Volti, S. L., Marino, S., Dibenedetto, S. P., Samperi, P., Testa, R., & Mollica, F. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909143211115 · Cited by 97
Multiple sclerosis and antecedent infections
Marrie, R. A., Wolfson, C. M., Sturkenboom, M., Gout, O., Heinzlef, O., Roullet, E., & Abenhaim, L. (2000) · Neurology · doi:10.1212/wnl.54.12.2307 · Cited by 96
Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis
Niederwieser, G., Buchinger, W., Bonelli, R. M., Berghold, A., Reisecker, F., K�ltringer, P., & Archelos, J. J. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1053-9 · Cited by 87
Agreement between GPRD smoking data: a survey of general practitioners and a population‐based survey
Lewis, J. D., & Brensinger, C. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.902 · Cited by 80
Self-citationAssociation of MS with thyroid disorders
Karni, A., & Abramsky, O. (1999) · Neurology · doi:10.1212/wnl.53.4.883 · Cited by 79
Current approved options for treating patients with multiple sclerosis
Rizvi, S., & Agius, M. A. (2004) · Neurology · doi:10.1212/wnl.63.12_suppl_6.s8 · Cited by 77
The distribution of multiple sclerosis in the United Kingdom.
Swingler, R. J., & Compston, D. A. S. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.10.1115 · Cited by 76
Possible Familial Association of Multiple Sclerosis and Inflammatory Bowel Disease
Minuk, G. Y., & Lewkonia, R. M. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602273140921 · Cited by 72
Surveying multiple sclerosis in the United Kingdom.
Robertson, N. P., & Compston, A. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.1.2 · Cited by 58
Fox, C., Bensa, S., Bray, I., & Zajicek, J. (2004) · PubMed · Cited by 57
The prevalence of multiple sclerosis in the Leeds Health Authority
Ford, H. L., Gerry, E., Airey, C. M., Vail, A., Johnson, M. H., & Williams, D. R. R. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.5.605 · Cited by 55
A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds
Ford, H. L., Gerry, E., Johnson, M. H., & Williams, R. (2002) · Journal of Neurology · doi:10.1007/s004150200002 · Cited by 52
Forbes, R. B., & Swingler, R. J. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009746 · Cited by 42
Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.
Robertson, N. P., Deans, J., Fraser, M., & Compston, D. A. S. (1996) · Journal of Epidemiology & Community Health · doi:10.1136/jech.50.3.274 · Cited by 39
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., Luckey, D. H., Marietta, E. V., Jeraldo, P. R., Chen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep28484 · Cited by 933
New IBD genetics: common pathways with other diseases
Lees, C. W., Barrett, J. C., Parkes, M., & Satsangi, J. (2011) · Gut · doi:10.1136/gut.2009.199679 · Cited by 635
Williams, B. L., Hornig, M., Buie, T., Bauman, M. L., Cho Paik, M., Wick, I., Bennett, A., Jabado, O., Hirschberg, D. L., & Lipkin, W. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024585 · Cited by 492
Acute Gastroenteritis Is Followed by an Increased Risk of Inflammatory Bowel Disease
Rodríguez, L. A. G., Ruigómez, A., & Panés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.004 · Cited by 369
Metadata
- Authors
- Gupta, G., Gelfand, J. M., & Lewis, J. D.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 129
- Issue
- 3
- Pages
- 819-826
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2002380690
- Cited by
- 265
- References
- 45
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.